Armata Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARMP and other ETFs, options, and stocks.

About ARMP

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA. 

CEO
Deborah L. Birx
CEODeborah L. Birx
Employees
61
Employees61
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
1989
Founded1989
Employees
61
Employees61

ARMP Key Statistics

Market cap
151.14M
Market cap151.14M
Price-Earnings ratio
-0.54
Price-Earnings ratio-0.54
Dividend yield
Dividend yield
Average volume
609.32K
Average volume609.32K
High today
$4.44
High today$4.44
Low today
$3.99
Low today$3.99
Open price
$4.43
Open price$4.43
Volume
306.91K
Volume306.91K
52 Week high
$16.34
52 Week high$16.34
52 Week low
$2.92
52 Week low$2.92

Stock Snapshot

Armata Pharmaceuticals(ARMP) stock is priced at $4.01, giving the company a market capitalization of 151.14M. It carries a P/E multiple of -0.54.

On 2026-09-17, Armata Pharmaceuticals(ARMP) stock moved within a range of $3.99 to $4.44. With shares now at $4.01, the stock is trading +0.6% above its intraday low and -9.7% below the session's peak.

Trading activity shows a volume of 306.91K, compared to an average daily volume of 609.32K.

Over the past 52 weeks, Armata Pharmaceuticals(ARMP) stock has traded between a high of $16.34 and a low of $2.92.

Over the past 52 weeks, Armata Pharmaceuticals(ARMP) stock has traded between a high of $16.34 and a low of $2.92.

ARMP News

TipRanks 3d
Armata wins FDA Breakthrough Therapy for AP-SA02

Armata Pharmaceuticals ( (ARMP) ) just unveiled an update. On September 14, 2026, Armata Pharmaceuticals announced that the U.S. Food and Drug Administration g...

TipRanks 3d
Armata Pharmaceuticals receives FDA Breakthrough Therapy Designation for AP-SA02

Armata Pharmaceuticals (ARMP) announced that the U.S. FDA has granted Breakthrough Therapy designation to AP-SA02, the company’s intravenously administered Stap...

People also own

Based on the portfolios of people who own ARMP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.